Position in BSX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,804
-$6,021 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,323
of 1,468 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $60,058 across 7 Medical Devices names. BSX ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
241 | $21,868 | |
| 2 | BSX |
Boston Scientific Corp
This page
|
300 | $12,804 | |
| 3 | EW |
Edwards Lifesciences Corp
|
96 | $8,684 | |
| 4 | MDT |
Medtronic plc
|
100 | $7,823 | |
| 5 | PODD |
Insulet Corp
|
40 | $6,090 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
|
100 | $1,509 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
20 | $1,280 |
All Filings in BSX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,804 | 300 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $18,825 | 300 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $28,605 | 300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,289 | 300 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $32,223 | 300 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $30,264 | 300 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,796 | 300 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $25,140 | 300 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,103 | 300 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $20,547 | 300 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $17,343 | 300 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $15,840 | 300 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $16,227 | 300 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $15,009 | 300 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $13,881 | 300 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $11,619 | 300 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $11,181 | 300 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,287 | 300 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $12,744 | 300 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $13,017 | 300 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $12,828 | 300 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $11,595 | 300 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $10,785 | 300 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $11,463 | 300 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $10,533 | 300 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $9,789 | 300 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||